Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Inverness Medical Innovations Inc. Stories

2011-11-14 02:00:00

OXFORD, England, November 14, 2011 /PRNewswire/ -- Concateno launches next-generation roadside drug testing device at Medica 2011 International police forces will now be able to target drug drivers quicker and easier, following the launch of a new roadside drug testing device developed by Concateno, Europe's leading drug and alcohol testing company. The Alere(TM) DDS(R)2 Mobile Test System, Concateno's next-generation handheld drug...

2011-11-03 07:45:00

MEDFORD, N.Y., Nov. 3, 2011 /PRNewswire/ -- Chembio Diagnostics, Inc. (OTC.PK: CEMI and OTC.QB: CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, reported revenues and earnings for the quarter ended September 30, 2011. Total revenues were $5.92 million for the quarter ended September 30, 2011, a quarterly record for the Company, which compares to total revenues of $4.51 million for the quarter ended September 30, 2010, a 31.5% increase. The Company...

2011-08-05 01:15:00

WALTHAM, Mass., Aug. 5, 2011 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will make a cash offer for the entire issued and to be issued ordinary share capital of Axis-Shield, whose shares are traded on the main market of the London Stock Exchange and on the Oslo Bors. Axis-Shield shareholders will be offered 460 pence (or...

2011-06-21 08:00:00

BEIJING, June 21, 2011 /PRNewswire-Asia/ -- Chinmax Medical Systems Inc., a leading cardiac biomarker distributor in China, announced today that it disclaims all liability in connection with an official letter it received from the China State Food and Drug Administration (SFDA) on June 2, 2011, in which the SFDA confirmed that it has investigated Inverness Medical Beijing (IMB), a subsidiary of Alere Inc. (NYSE: ALR), and suspects IMB of submitting of a forged copy of the Triage BNP Test...

2011-04-11 08:00:00

BEIJING, April 11, 2011 /PRNewswire-Asia/ -- Chinmax Medical Systems Inc., a leading cardiac biomarker distributor in China announced an update regarding the progress of its lawsuit against Inverness Medical Beijing (IMB), a subsidiary of Alere Inc.(NYSE: ALR). According to the Complaint, Inverness Medical Beijing secretly imported massive quantities of Triage product and sold the same to Chinmax customers during the period when Chinmax retained the undisputed contractual rights as...

2010-07-28 07:15:00

WALTHAM, Mass., July 28 /PRNewswire-FirstCall/ -- Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced its financial results for the quarter ended June 30, 2010. Financial results for the second quarter of 2010: Net revenue of $523.0 million for the second quarter of 2010, compared to $438.7 million for the...

2010-07-19 09:49:00

ATLANTA, July 19 /PRNewswire/ -- Like all the King's men in the Humpty Dumpty nursery rhyme, U.S. healthcare leaders are searching for ways to put our fractured healthcare system "back together again." That fact and analogy are focal points of a presentation by Gordon Norman, MD, chief innovation officer for Alere, at the Seventh Annual Healthcare Unbound Conference, July 19-20 in San Diego. Dr. Norman's presentation will highlight the various participants within the healthcare...

2010-07-15 15:26:00

WALTHAM, Mass., July 15 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has changed its name to Alere Inc., after shareholders approved the name change at its Annual Meeting of Stockholders held on July 14, 2010. The Company also announced that it expects its NYSE stock symbol to change from "IMA"...

2010-06-08 09:45:00

ATLANTA, June 8 /PRNewswire/ -- Finding the strategies that will help employers and health plans successfully adapt to the changing healthcare environment will be a focal point of a presentation given by Gordon Norman, MD, MBA, chief innovation officer for Alere, at AHIP's Institute 2010 June 9-11 in Las Vegas. Alere is a patient-centered health management company serving large employers and health plans nationwide. (Logo: http://photos.prnewswire.com/prnh/20100603/CL15025LOGO )...

2010-06-07 07:30:00

WALTHAM, Mass., June 7 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA) announced today that it has further extended its offer to exchange up to $100,000,000 in aggregate principal amount of 7.875% Senior Notes due 2016 (the "Notes") that have been registered under the Securities Act of 1933, as amended, for a like principal amount of its outstanding unregistered 7.875% Senior Notes due 2016, to 5:00 p.m., New York City time, on Friday, June 11, 2010, unless further...